ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

GE HealthCare’s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance

  • CARESCAPE Canvas builds on GE HealthCare’s 50+ years of clinical excellence and provides a unified patient monitoring solution that is reliable, flexible, scalable and intuitive to use

GE HealthCare (Nasdaq: GEHC) today announced US FDA 510(k) clearance of its CARESCAPE Canvas patient monitoring platform for precise, flexible patient care. CARESCAPE Canvas and CARESCAPE ONE are part of an adaptable ecosystem that can easily scale up and scale down monitoring capabilities based on the acuity of each individual patient, delivered on a standardized platform that drives enterprise efficiency and ease of service.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230420005615/en/

CARESCAPE Canvas in the NICU (Photo: Business Wire)

CARESCAPE Canvas in the NICU (Photo: Business Wire)

“As patient acuity and disease trends change rapidly, adaptability in the hospital setting is becoming more important. We look for ways to improve the care experience by delivering quality clinical measurements where and when they are needed, giving care providers the information they need to make the best possible clinical decisions,” Dr. Roland Schrewe, head of PICU, University of Frankfurt. “GE HealthCare’s CARESCAPE Canvas provides a precise, standardized and flexible patient monitoring solution that adapts to patient needs with the ease of switching out a cable.”

CARESCAPE Canvas is a FlexAcutity solution equipped with smart parameter technology that can be used for patients at all levels of acuity. This monitoring platform offers flexibility, standardization and ease of use by leveraging micromodules that connect with standardized medical USB technology -- simply adding or disconnecting cables equipped for various configurations enables more efficient care based on patient care needs. It is also equipped with flexible, easy to configure software and interchangeable frames for advanced parameters, enable monitoring devices to be quickly redeployed across the hospital enterprise as needed.

“This new monitoring ecosystem has the potential for a hospital to have one single unified approach to patient monitoring that can be easily tailored for each patient,” said Neal Sandy, general manager, monitoring solutions, GE HealthCare. “GE HealthCare is committed to offering flexible solutions that enable care teams to focus on the patient, not the technology. CARESCAPE Canvas’ innovative approach, where software and patient parameters can change in a very nimble manner, enable a standardized ecosystem that can adapt to changing healthcare needs.”

The CARESCAPE Canvas bedside monitor was developed and tested with the rest of GE HealthCare’s ecosystem, not only with the current devices available, but also with prior versions that are used across the 100 million patients monitored by GE HealthCare devices each year. This backward compatibility allows healthcare systems to upgrade to the latest capabilities at their pace. CARESCAPE Canvas was also developed with sustainability in mind, with a 53% reduction in packaging volume1, 48% reduction in packaging weight compared to previous generation monitor1, and a 25% reduction in energy consumption compared to previous models2. In addition, CARESCAPE Canvas monitors made at GE HealthCare’s Helsinki site are manufactured by using 100% renewable wind electricity3.

CARESCAPE Canvas was recently awarded the world-renowned, iF Design Award 2023. The jury prize honors design achievements in all disciplines and recognized CARESCAPE Canvas for product design in medicine/health.

CARESCAPE Canvas has been approved for use in the EU since June, 2022 and is now cleared for use in the US.

ABOUT GE HEALTHCARE TECHNOLOGIES INC.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from prevention and screening, to diagnosis, treatment, therapy, and monitoring. We are an $18 billion business with 50,000 employees working to create a world where healthcare has no limits.

Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights for the latest news, or visit our website www.gehealthcare.com for more information.

-----------------------------

1 CARESCAPE Canvas package is 53% smaller and packaging material mass is 48% lighter than the packaging of the equivalent CARESCAPE B850 monitor.

2 CARESCAPE Canvas 1000 system uses 255 less energy than the CARESCAPE B850 system with the same setup.

3 CARESCAPE Canvas 1000 is produced in Finland with renewable wind energy.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.16
-0.51 (-0.22%)
AAPL  277.55
+0.58 (0.21%)
AMD  214.24
+8.11 (3.93%)
BAC  52.99
+0.51 (0.97%)
GOOG  320.28
-3.36 (-1.04%)
META  633.61
-2.61 (-0.41%)
MSFT  485.50
+8.51 (1.78%)
NVDA  180.26
+2.44 (1.37%)
ORCL  204.96
+7.93 (4.02%)
TSLA  426.58
+7.18 (1.71%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.